Brief: FDA Boston Scientific Removes Certain Axios Stents And Electrocautery-Enhanced Delivery Systems
Feb 25 (Reuters) - Boston Scientific Corp BSX.N: FDA: BOSTON SCIENTIFIC REMOVES CERTAIN AXIOS STENTS AND ELECTROCAUTERY-ENHANCED DELIVERY SYSTEMS- WEBSITE FDA: AS OF DEC 23, BOSTON SCIENTIFIC HAS REPORTED 167 SERIOUS INJURIES, AND THREE DEATHS ASSOCIATED WITH STENT ISSUE Further company coverage: BSX.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Boston Scientific
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
U.S. RESEARCH ROUNDUP-Autodesk, Dell Technologies, Hyatt Hotels
Live Markets: Eight trillion reasons UBS wants you to bet on longevity
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
U.S. STOCKS ON THE MOVE-Boston Scientific, Banc of California, Salesforce